A simple wish to free up time and capacity, and also to share knowledge between Denmark and Norway, is behind biotech group Amgen's decision to join its Danish and Norwegian divisions into one unit with a shared management team, says Tore von Würden, Amgen's country director of Denmark and Iceland, who has been tasked with spearheading the new unit.
"We think there is a lot of development potential in doing this, both for the individual and the individual unit, as we now have the opportunity to free up some energy to share knowledge between the organizations, allowing individual employees to become more skilled and to bring ideas with them to the other market," says von Würden, adding:
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.